Skip to main content
ArticleOPEN ACCESS

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer

The Lancet Oncology
DOI: 10.1016/S1470-2045(17)30170-5
6Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Yan, W., Zhou, Y., Zhou, Z., Ji, Z., & Li, H. (2017, April 1). Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer. The Lancet Oncology. Lancet Publishing Group. https://doi.org/10.1016/S1470-2045(17)30170-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free